Holen Sie sich die Stockscreener-App
3.36
2.38%
0.0781
Handel nachbörslich:
3.36
Schlusskurs vom Vortag:
$3.2819
Offen:
$3.31
24-Stunden-Volumen:
27,744
Relative Volume:
0.71
Marktkapitalisierung:
$4.45M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-38.35M
KGV:
-2.3172
EPS:
-1.45
Netto-Cashflow:
$-36.91M
1W Leistung:
-1.18%
1M Leistung:
-4.95%
6M Leistung:
-26.64%
1J Leistung:
-75.17%
1-Tages-Spanne:
$3.17
$3.45
1-Wochen-Bereich:
$3.17
$3.45
52-Wochen-Spanne:
$2.01
$15.13
Galecto Inc Stock (GLTO) Company Profile
Firmenname
Galecto Inc
Sektor
Branche
Telefon
45-70-70-52-10
Adresse
75 STATE STREET, BOSTON
Vergleichen Sie GLTO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GLTO
Galecto Inc
|
3.36 | 4.35M | 0 | -38.35M | -36.91M | -1.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Galecto Inc Stock (GLTO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-11-23 | Eingeleitet | BofA Securities | Buy |
| 2020-11-23 | Eingeleitet | Credit Suisse | Outperform |
| 2020-11-23 | Eingeleitet | SVB Leerink | Outperform |
Galecto Inc Aktie (GLTO) Neueste Nachrichten
Why Galecto Inc. stock attracts strong analyst attentionBull Run & Fast Exit and Entry Trade Guides - thegnnews.com
What makes Galecto Inc. stock price move sharplyVolume Spike & Fast Exit Strategy with Risk Control - Newser
Real time scanner hits for Galecto Inc. explainedWeekly Earnings Recap & AI Enhanced Trading Signals - Newser
What to do if you’re stuck in Galecto Inc.2025 Big Picture & Safe Entry Zone Identification - Newser
How SPYU stock compares to its top competitorsIs Galecto Inc. stock undervalued or overvalued now2025 Trading Recap & Verified Swing Trading Watchlists - Newser
Can swing trading help recover from Galecto Inc. lossesBear Market Safe Zone Technical Analysis - Newser
What makes KVH Industries Inc. stock price move sharplyLong-Term Growth Trend Summary With Confidence - Newser
Will Galecto Inc. continue its uptrendFree Weekly Stock Opportunity Radar Scanner - Newser
Is Galecto Inc. stock trending bullishSmart Beta Portfolio Candidates - newsyoung.net
Sectors Driving Future Growth for Galecto Inc. StockFree Safe Entry Stock Watch Suggestions - Newser
Price action breakdown for Galecto Inc.Free Smart Allocation Stock Pick Insights - Newser
Using Ichimoku Cloud for Galecto Inc. technicalsRisk Aware Trading Ideas with Alert Levels - Newser
Intraday pattern recognizer results for Galecto Inc.Day Trading Setup Forecast with Trend Model - Newser
What MACD signals say about Galecto Inc.Annual Market Behavior and Sector Summary - Newser
Risk vs reward if holding onto Galecto Inc.AI Swing Strategy Signal Forecasting System - Newser
Technical analysis overview for Galecto Inc. stockFree Stock Market Watch With Alerts - Newser
Long term hold vs stop loss in OmniAb Inc. Equity WarrantHigh Win Rate Strategy with Stop Protection - Newser
Chart based exit strategy for Galecto Inc.Free Buy Low Sell High Stock Watch - Newser
Can Galecto Inc. deliver alphaLow Risk Entry Stock List - kangso.co.kr
Can trapped investors hope for a rebound in Galecto Inc.Free Oversold Recovery Opportunity Stocks - Newser
Galecto, Inc. Focuses on Oncology and Liver Disease - TipRanks
Galecto Reports Q2 GAAP EPS of -$2.60, Cash at $10.2M - AInvest
Galecto Reports Second Quarter 2025 Operating and Financial Resu - GuruFocus
Galecto's Strategic Path to IND Submission and Financial Sustainability - AInvest
Galecto Reports Second Quarter 2025 Operating and Financial Results - The Manila Times
Galecto, Inc. Reports Second Quarter 2025 Financial Results and Progress on GB3226 Development for AML - Quiver Quantitative
Galecto Reports Q2 Earnings: Novel Dual-Inhibitor Drug Shows Promise Against Treatment-Resistant AML - Stock Titan
Published on: 2025-08-04 08:22:04 - Newser
Is Galecto Inc. a growth stock or a value stockMaximize your returns with smart trade entries - Jammu Links News
Is Galecto Inc. stock overvalued or undervaluedExceptional risk-adjusted gains - Jammu Links News
How does Galecto Inc. generate profit in a changing economySuperior profit margins - Jammu Links News
Is Galecto Inc. a good long term investmentExceptional gains - Jammu Links News
What are analysts’ price targets for Galecto Inc. in the next 12 monthsExpert guidance for superior capital growth - Jammu Links News
Finanzdaten der Galecto Inc-Aktie (GLTO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):